Primary Health Props - Director/PDMR Shareholding

Primary Health Properties

23/09/2025 16:00

RNS Number : 4936A

Primary Health Properties PLC

23 September 2025

 

Primary Health Properties PLC

Director's & PDMR dealings

On 25 February 2025, the remuneration committee of Primary Health Properties PLC (the "Company" or "PHP") approved the following awards of nil-cost options under the Company's 2021 Long-term Incentive Plan ("LTIP") to Directors and Persons Discharging Managerial Responsibilities ("PDMR's").  These awards, deferred because the Company was subsequently in a prolonged closed period, have now been made on 23 September 2025.

Director
Number of shares under option
Mark Davies
969,643
Richard Howell
670,438
PDMR
David Austin
137,224
Toby Newman
120,421

 

The number of nil-cost options were calculated by reference to a price of £0.8927, being the average of the closing middle market quotations for the Company's ordinary shares on 17, 18 and 19 September 2025. 

The nil-cost options will vest subject to the attainment of performance conditions measured over three years to 31 December 2027.  The remuneration committee has the discretion to adjust the awards downwards at vesting for malus reasons.  Details of the operation of the LTIP are set out in the Company's 2023 Report and Accounts.

Details of the transactions referenced above are included below in accordance with the under Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).

1
Details of the person discharging managerial responsibilities/person closely associated
(a)
Name
Mark Davies
2
Reason for notification
(a)
Position/Status
Chief Executive Officer
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Primary Health Properties PLC
(b)
LEI
213800Y5CJHXOATK7X11
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument, type of instrument and identification code
Ordinary shares of 12.5p
ISIN:GB00BYRJ5J14
(b)
Nature of transaction
Award of nil-cost options over the Company's ordinary shares
(c)
Price(s) and volume(s)
Price(s)
Volume(s)
Nil cost
969,643
(d)
Aggregated Information
Single transaction: N/A
(e)
Date of transaction
23 September 2025
(f)
Place of transaction
N/A

 

 

1
Details of the person discharging managerial responsibilities/person closely associated
(a)
Name
Richard Howell
2
Reason for notification
(a)
Position/Status
Chief Financial Officer
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Primary Health Properties PLC
(b)
LEI
213800Y5CJHXOATK7X11
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument, type of instrument and identification code
Ordinary shares of 12.5p
ISIN:GB00BYRJ5J14
(b)
Nature of transaction
Award of nil-cost options over the Company's ordinary shares
(c)
Price(s) and volume(s)
Price(s)
Volume(s)
Nil cost
670,438
(d)
Aggregated Information
Single transaction: N/A
(e)
Date of transaction
23 September 2025
(f)
Place of transaction
N/A

 

1
Details of the person discharging managerial responsibility/person closely associated
(a)
Name
David Austin
2
Reason for notification
(a)
Position/Status
PDMR
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Primary Health Properties PLC
(b)
LEI
213800Y5CJHXOATK7X11
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument, type of instrument and identification code
Ordinary shares of 12.5p
ISIN:GB00BYRJ5J14
(b)
Nature of transaction
Award of nil-cost options over the Company's ordinary shares
(c)
Price(s) and volume(s)
Price(s)
Volume(s)
Nil cost
137,224
(d)
Aggregated Information
Single transaction: N/A
(e)
Date of transaction
23 September 2025
(f)
Place of transaction
N/A

 

1
Details of the person discharging managerial responsibilities/person closely associated
(a)
Name
Toby Newman
2
Reason for notification
(a)
Position/Status
Company Secretary & Chief Legal Officer
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Primary Health Properties PLC
(b)
LEI
213800Y5CJHXOATK7X11
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument, type of instrument and identification code
Ordinary shares of 12.5p
ISIN:GB00BYRJ5J14
(b)
Nature of transaction
Award of nil-cost options over the Company's ordinary shares
(c)
Price(s) and volume(s)
Price(s)
Volume(s)
Nil cost
120,421
(d)
Aggregated Information
Single transaction: N/A
(e)
Date of transaction
23 September 2025
(f)
Place of transaction
N/A

 

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk

 

Further details:

Mark Davies
Chief Executive Officer
via Burson Buchanan
Tel: +44 (0) 20 7466 5066
Richard Howell
Chief Financial Officer
via Burson Buchanan
Tel: +44 (0) 20 7466 5066
Stephanie Whitmore (Burson Buchanan)
Tel: +44 (0) 20 7466 5066


 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBXGDCISDDGUX